RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops …
Over the last 12 months, insiders at RadNet, Inc. have bought $0 and sold $18.75M worth of RadNet, Inc. stock.
On average, over the past 5 years, insiders at RadNet, Inc. have bought $249,748 and sold $6.64M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,519 shares for transaction amount of $151,271 was made by SWARTZ DAVID L (director) on 2021‑08‑11.
2024-08-21 | Sale | EVP, Mergers and Acquisitions | 15,000 0.0202% | $62.78 | $941,702 | +7.17% | ||
2024-06-18 | Sale | EVP, Chief Admin Officer | 29,800 0.0389% | $59.00 | $1.76M | +12.45% | ||
2024-06-18 | Sale | director | 7,167 0.0095% | $59.75 | $428,228 | +12.45% | ||
2024-06-17 | Sale | EVP, Chief Admin Officer | 10,200 0.0136% | $60.00 | $612,000 | +11.75% | ||
2024-06-17 | Sale | director | 7,167 0.0095% | $59.75 | $428,228 | +11.75% | ||
2024-06-14 | Sale | director | 4,000 0.0051% | $57.77 | $231,080 | +11.44% | ||
2024-06-12 | Sale | EVP, Chief Science Officer | 10,000 0.0138% | $62.34 | $623,400 | +5.51% | ||
2024-06-12 | Sale | Pres & COO-Eastern Operations | 40,000 0.0552% | $62.33 | $2.49M | +5.51% | ||
2024-06-12 | Sale | Pres and COO-West Operations | 18,597 0.026% | $63.08 | $1.17M | +5.51% | ||
2024-06-12 | Sale | director | 4,066 0.0056% | $62.42 | $253,800 | +5.51% | ||
2024-06-12 | Sale | EVP, Mergers and Acquisitions | 10,000 0.0138% | $62.51 | $625,100 | +5.51% | ||
2024-06-11 | Sale | EVP, Chief Science Officer | 5,000 0.0068% | $61.24 | $306,200 | +6.49% | ||
2024-06-11 | Sale | Pres and COO-West Operations | 35,000 0.0476% | $61.40 | $2.15M | +6.49% | ||
2024-06-10 | Sale | director | 20,934 0.0279% | $60.43 | $1.27M | +5.79% | ||
2024-06-10 | Sale | director | 16,000 0.0214% | $60.85 | $973,600 | +5.79% | ||
2024-06-10 | Sale | EVP, Chief Financial Officer | 25,000 0.0337% | $61.27 | $1.53M | +5.79% | ||
2024-06-10 | Sale | Pres and COO-West Operations | 20,000 0.0269% | $61.13 | $1.22M | +5.79% | ||
2024-06-10 | Sale | director | 1,500 0.002% | $61.03 | $91,545 | +5.79% | ||
2024-06-07 | Sale | EVP and Chief Legal Officer | 16,400 0.0222% | $61.26 | $1M | +6.16% | ||
2024-06-07 | Sale | director | 3,000 0.0041% | $61.30 | $183,900 | +6.16% |
SWARTZ DAVID L | director | 196476 0.2654% | $81.72 | 1 | 4 | <0.0001% |
Levitt Lawrence L | director | 172657 0.2332% | $81.72 | 2 | 6 | +20.47% |
SHERMAN MICHAEL L MD | director | 259083 0.35% | $81.72 | 1 | 5 | +7.31% |
Karen B. Kaplan Survivor's Trust | 21000 0.0284% | $81.72 | 1 | 0 | +169.3% |
BlackRock | $450.51M | 12.53 | 9.26M | +4.09% | +$17.72M | 0.01 | |
The Vanguard Group | $223.86M | 6.23 | 4.6M | +8.13% | +$16.83M | <0.01 | |
BECK MACK + OLIVER | $163.19M | 4.54 | 3.35M | +3.83% | +$6.02M | 3.31 | |
State Street | $113.57M | 3.16 | 2.33M | +5.06% | +$5.47M | 0.01 | |
Jb Capital Partners Lp | $97.67M | 2.72 | 2.01M | -5.64% | -$5.84M | 3.21 |